Development of novel fluorinated reagents for preparation of drugs.

Informacje na temat projektu

FLUNOVELTY

Identyfikator umowy o grant: 654260

DOI 10.3030/654260

Projekt został zamknięty

Data podpisania przez KE 26 Marca 2015

Data rozpoczęcia 1 Listopada 2015

Data zakończenia 31 Października 2016

Finansowanie w ramach

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Koszt całkowity € 92 538,00

Wkład UE € 92 538,00

Koordynowany przez

ECOLE SUPERIEURE DE PHYSIQUE ET DECHIMIE INDUSTRIELLES DE LA VILLE DEPARIS
France

Cel

Around 20% of all modern drugs are fluorinated organic molecules. During the recent years, however, pharmaceutical companies struggle to deliver novel drugs to the market, because of the lack of innovative practical reagents and reactions towards “drug-like” compounds.
In this project, we will address this issue by discovering novel small fluorinating reagents - fluorinated diazoalkanes, - elaborate their practical reactions, and use this knowledge to develop alternative synthetic approaches to some known drugs (AS-136A, Celecoxib).

Dziedzina nauki

• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs

Program(-y)

• H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions Main Programme
• H2020-EU.1.3.2. - Nurturing excellence by means of cross-border and cross-sector mobility

Temat(-y)

• MSCA-IF-2014-EF - Marie Skłodowska-Curie Individual Fellowships (IF-EF)

Zaproszenie do składania wniosków

H2020-MSCA-IF-2014

System finansowania

MSCA-IF-EF-ST - Standard EF

Koordynator

ECOLE SUPERIEURE DE PHYSIQUE ET DECHIMIE INDUSTRIELLES DE LA VILLE DEPARIS

• Wkład UE netto: € 92 538,00
• Adres: RUE VAUQUELIN 10 ; 75231 Paris ; Francja
• Region: Ile-de-France › Ile-de-France › Paris
• Rodzaj działalności: Higher or Secondary Education Establishments
• Koszt całkowity: € 92 538,00